P53 alterations in bladder tumors from arsenic and tobacco exposed patients
Previous studies demonstrated that tobacco and arsenic exposure are risk factors for bladder cancer. A case-case study was conducted to compare p53 mutations in 147 bladder tumors from South American patients by tobacco and arsenic exposure. Information on residential history and lifestyle factors w...
Guardado en:
| Autores principales: | Moore, Lee E., Smith, Allan H., Eng, Clarence, Devries, Sandy, Kalman, Dave, Bhargava, Vivek, Chew, Karen, Ferreccio, Catterina, Rey, Omar A., Hopenhayn, Claudia, Biggs, Mary Lou, Bates, Michael N. |
|---|---|
| Formato: | Artículo acceptedVersion |
| Lenguaje: | Español |
| Publicado: |
2003
|
| Materias: | |
| Acceso en línea: | http://pa.bibdigital.ucc.edu.ar/3955/1/A_Moore_Smith_Eng_DeVries_Kalman_Bhargava_Chew_Ferreccio_Rey_Hopenhayn_Biggs_Bates_Waldman.pdf |
| Aporte de: |
Ejemplares similares
-
Arsenic methylation and bladder cancer risk in case-control studies in Argentina and the United States
por: Steinmaus, Craig, et al.
Publicado: (2006) -
Tumors of the urinary bladder /
por: Friedman, Nathan B.
Publicado: (1959) -
Bladder cancer : diagnosis and clinical management /
Publicado: (2015) -
Bladder cancer and mate consumption in Argentina: a case-control study
por: Bates, Michael N., et al.
Publicado: (2007) -
Genetic polymorphisms in MTHFR 677 and 1298, GSTM1 and T1, and metabolism of arsenic
por: Streinmaus, Craig, et al.
Publicado: (2007)